Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

類似資料

• Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
  著者:: Vitek, M P, 等
  出版事項: (1994)
• Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products
  著者:: Wang, Xingyu, 等
  出版事項: (1998)
• Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
  著者:: Bucala, R, 等
  出版事項: (1993)
• Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
  著者:: Vlassara, H, 等
  出版事項: (1992)
• Acrolein Consumption Induces Systemic Dyslipidemia and Lipoprotein Modification
  著者:: Conklin, Daniel J., 等
  出版事項: (2009)